Neoadjuvant therapy
Improved Neoadjuvant Chemo Prediction for HR+HER2- ESBC with MP High 2
21st Bossche Mamma Congress 2024, P07 Presenter: O'Shaughnessy et al.
Read MoreNeoadjuvant therapy
21st Bossche Mamma Congress 2024, P07 Presenter: O'Shaughnessy et al.
Read MoreElucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer
Read MoreSSO 2024 Author: Solis-Pomales et al.
Read MoreThe Breast 75 (2024) 103726 Presenter: van Olmen et al.
Read MoreJournal of Clinical Oncology, April 9, 2024 Presenter: Rios-Hoyo et al.
Read MoreEBCC 2024, Oral Presentation Presenter: Dr. Caroline Drukker
Read MoreMiami Breast 2024, Poster 36 Authors: Audeh et al.
Read MoreMiami Breast 2024, Poster 29 Authors: Audeh et al.
Read MoreSABCS 2023, PO5-15-04 Authors: O'Shaughnessy et al.
Read MoreSABCS 2023, PO1-28-01 Authors: Sonya Reid et al.
Read More